Evidence map›Paper›PMID 32432672›Full record

ArticleThe Journal of infectious diseases2020

Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces.

Shanna Ratnesar-Shumate, Gregory Williams, Brian Green, Melissa Krause, Brian Holland, Stewart Wood, Jordan Bohannon, Jeremy Boydston, Denise Freeburger, Idris Hooper and 9 more

Abstract readComment
In one paragraph

Article in The Journal of infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 192 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
192citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

192 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Disinfection methods against SARS-CoV-2: a systematic review.The Journal of hospital infection · 2022
    Pooled it
  4. Surface contamination with SARS-CoV-2: A systematic review.The Science of the total environment · 2021
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

132 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Shanna Ratnesar-ShumateNational Biodefense Analysis and Countermeasures Center, Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
Gregory WilliamsNational Biodefense Analysis and Countermeasures Center, Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
Brian GreenNational Biodefense Analysis and Countermeasures Center, Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
Melissa KrauseNational Biodefense Analysis and Countermeasures Center, Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
Brian HollandNational Biodefense Analysis and Countermeasures Center, Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
Stewart WoodNational Biodefense Analysis and Countermeasures Center, Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
Jordan BohannonNational Biodefense Analysis and Countermeasures Center, Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
Jeremy BoydstonNational Biodefense Analysis and Countermeasures Center, Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
Denise FreeburgerNational Biodefense Analysis and Countermeasures Center, Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
Idris HooperNational Biodefense Analysis and Countermeasures Center, Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
Katie BeckNational Biodefense Analysis and Countermeasures Center, Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
John YeagerNational Biodefense Analysis and Countermeasures Center, Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
Louis A AltamuraNational Biodefense Analysis and Countermeasures Center, Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
Jennifer BiryukovNational Biodefense Analysis and Countermeasures Center, Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
Jason YolitzNational Biodefense Analysis and Countermeasures Center, Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
Michael SchuitNational Biodefense Analysis and Countermeasures Center, Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
Victoria WahlNational Biodefense Analysis and Countermeasures Center, Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
Michael HeveyNational Biodefense Analysis and Countermeasures Center, Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
Paul DabischNational Biodefense Analysis and Countermeasures Center, Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies have demonstrated that SARS-CoV-2 is stable on surfaces for extended periods under indoor conditions. In the present study, simulated sunlight rapidly inactivated SARS-CoV-2 suspended in either simulated saliva or culture media and dried on stainless steel coupons. Ninety percent of infectious virus was inactivated every 6.8 minutes in simulated saliva and every 14.3 minutes in culture media when exposed to simulated sunlight representative of the summer solstice at 40°N latitude at sea level on a clear day. Significant inactivation also occurred, albeit at a slower rate, under lower simulated sunlight levels. The present study provides the first evidence that sunlight may rapidly inactivate SARS-CoV-2 on surfaces, suggesting that persistence, and subsequently exposure risk, may vary significantly between indoor and outdoor environments. Additionally, these data indicate that natural sunlight may be effective as a disinfectant for contaminated nonporous materials.

Indexed as

BetacoronavirusCoronavirus InfectionsPandemicsPneumonia, ViralSevere acute respiratory syndrome-related coronavirusCOVID-19HumansSARS-CoV-2SunlightCOVID-19environmental persistenceSARS-CoV-2sunlight

Identifiers

PMID32432672
PMCPMC7313905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.